Predictors of Hyperkalemia in Pediatric Patients on Dialysis: International Prospective Observational Study

Overview

Journal Pediatr Nephrol

Specialties Nephrology
Pediatrics

Date 2025 Mar 13

PMID 40080184

Authors

Fabio Paglialonga

Rukshana Shroff

Ilona Zagozdzon

Sevcan A Bakkaloglu

Ariane Zaloszyc

Augustina Jankauskiene

Alejandro Cruz Gual

Maria R Grassi

Louise McAlister

Aleksandra Skibiak

Burcu Yazicioglu

Giuseppe Puccio

Francesca Sofia Grassi

Silvia Consolo

Alberto Edefonti

Affiliations

Soon will be listed here.

Abstract

Background: Hyperkalemia is an important issue in kidney failure. The aim of the study was to investigate the predictors of hyperkalemia in children receiving maintenance dialysis.

Methods: This was an international prospective cross-sectional observational study involving patients < 18 years receiving chronic hemodialysis or peritoneal dialysis. Hyperkalemia was defined as serum potassium (sK) ≥ 5 mEq/L based on the Pediatric Renal Nutrition Taskforce recommendations. We recorded age, dialysis vintage, urine output (24-h urine collection); dietary K, energy, protein and sodium intake (three-day diaries); office blood pressure (BP) in children < 5 years and 24-h ABPM in older patients; biochemistry (creatinine, urea, sodium, bicarbonate, hemoglobin, phosphate, albumin) and antihypertensive drugs.

Results: Forty-one patients were enrolled (10 peritoneal dialysis, 31 hemodialysis), median age 13.3 (IQR 10.6-15.8) years; 15 of them (36.6%) showed hyperkalemia, and median sK was 4.7 (4.4-5.0) mEq/L. Renin-angiotensin-aldosterone system inhibitors (RAASi) were prescribed in 9/15 patients with hyperkalemia (60%) and 7/26 (26.9%) without hyperkalemia (p = 0.04). Patients with hyperkalemia were older and had higher urea and creatinine than those with normal sK. A backward stepwise multivariable model showed that the only predictors of hyperkalemia were age (b = 0.53, p = 0.01), urea (b = 0.02, p = 0.03) and treatment with RAASi (b = 2.75, p = 0.021).

Conclusions: While higher age, higher urea levels and treatment with RAASi independently predicted the occurrence of hyperkalemia, K intake was not associated with sK in children on dialysis. This emphasizes the importance of considering non-dietary causes of hyperkalemia and considering the bioavailability of K more than the total dietary K intake.

References

Clase C, Carrero J, Ellison D, Grams M, Hemmelgarn B, Jardine M . Potassium homeostasis and management of dyskalemia in kidney diseases: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. Kidney Int. 2019; 97(1):42-61. DOI: 10.1016/j.kint.2019.09.018. View

Thomsen R, Nicolaisen S, Hasvold P, Sanchez R, Pedersen L, Adelborg K . Elevated potassium levels in patients with chronic kidney disease: occurrence, risk factors and clinical outcomes-a Danish population-based cohort study. Nephrol Dial Transplant. 2017; 33(9):1610-1620. DOI: 10.1093/ndt/gfx312. View

Desloovere A, Renken-Terhaerdt J, Tuokkola J, Shaw V, Greenbaum L, Haffner D . The dietary management of potassium in children with CKD stages 2-5 and on dialysis-clinical practice recommendations from the Pediatric Renal Nutrition Taskforce. Pediatr Nephrol. 2021; 36(6):1331-1346. PMC: 8084813. DOI: 10.1007/s00467-021-04923-1. View

Luo J, Brunelli S, Jensen D, Yang A . Association between Serum Potassium and Outcomes in Patients with Reduced Kidney Function. Clin J Am Soc Nephrol. 2015; 11(1):90-100. PMC: 4702219. DOI: 10.2215/CJN.01730215. View

Hoppe L, Muhlack D, Koenig W, Carr P, Brenner H, Schottker B . Association of Abnormal Serum Potassium Levels with Arrhythmias and Cardiovascular Mortality: a Systematic Review and Meta-Analysis of Observational Studies. Cardiovasc Drugs Ther. 2018; 32(2):197-212. DOI: 10.1007/s10557-018-6783-0. View

Kovesdy C, Regidor D, Mehrotra R, Jing J, McAllister C, Greenland S . Serum and dialysate potassium concentrations and survival in hemodialysis patients. Clin J Am Soc Nephrol. 2007; 2(5):999-1007. DOI: 10.2215/CJN.04451206. View

Genovesi S, Valsecchi M, Rossi E, Pogliani D, Acquistapace I, De Cristofaro V . Sudden death and associated factors in a historical cohort of chronic haemodialysis patients. Nephrol Dial Transplant. 2009; 24(8):2529-36. DOI: 10.1093/ndt/gfp104. View

Hui W, Betoko A, Savant J, Abraham A, Greenbaum L, Warady B . Assessment of dietary intake of children with chronic kidney disease. Pediatr Nephrol. 2016; 32(3):485-494. PMC: 5642285. DOI: 10.1007/s00467-016-3491-5. View

Chen W, Ducharme-Smith K, Davis L, Hui W, Warady B, Furth S . Dietary sources of energy and nutrient intake among children and adolescents with chronic kidney disease. Pediatr Nephrol. 2017; 32(7):1233-1241. PMC: 5633852. DOI: 10.1007/s00467-017-3580-0. View

10.

Tuokkola J, Kiviharju E, Jahnukainen T, Holtta T . Differences in Dietary Intake and Vitamin and Mineral Status of Infants and Children on Dialysis Receiving Feeds or Eating Normal Food. J Ren Nutr. 2020; 31(2):144-154. DOI: 10.1053/j.jrn.2020.07.003. View

11.

Le Palma K, Pavlick E, Copelovitch L . Pretreatment of enteral nutrition with sodium polystyrene sulfonate: effective, but beware the high prevalence of electrolyte derangements in clinical practice. Clin Kidney J. 2018; 11(2):166-171. PMC: 5887418. DOI: 10.1093/ckj/sfx138. View

12.

Fassinger N, Dabbagh S, Mukhopadhyay S, Lee D . Mineral content of infant formula after treatment with sodium polystyrene sulfonate or calcium polystyrene sulfonate. Adv Perit Dial. 2000; 14:274-7. View

13.

Schroder C, van den Berg A, Willems J, Monnens L . Reduction of potassium in drinks by pre-treatment with calcium polystyrene sulphonate. Eur J Pediatr. 1993; 152(3):263-4. DOI: 10.1007/BF01956159. View

14.

Taylor J, Oladitan L, Carlson S, Hamilton-Reeves J . Renal formulas pretreated with medications alters the nutrient profile. Pediatr Nephrol. 2015; 30(10):1815-23. PMC: 4572699. DOI: 10.1007/s00467-015-3115-5. View

15.

Paloian N, Bowman B, Bartosh S . Treatment of infant formula with patiromer dose dependently decreases potassium concentration. Pediatr Nephrol. 2019; 34(8):1395-1401. DOI: 10.1007/s00467-019-04232-8. View

16.

Khandelwal P, Shah S, McAlister L, Cleghorn S, King L, Shroff R . Safety and efficacy of sodium zirconium cyclosilicate for the management of acute and chronic hyperkalemia in children with chronic kidney disease 4-5 and on dialysis. Pediatr Nephrol. 2023; 39(4):1213-1219. DOI: 10.1007/s00467-023-06176-6. View

17.

Lurbe E, Agabiti-Rosei E, Cruickshank J, Dominiczak A, Erdine S, Hirth A . 2016 European Society of Hypertension guidelines for the management of high blood pressure in children and adolescents. J Hypertens. 2016; 34(10):1887-920. DOI: 10.1097/HJH.0000000000001039. View

18.

Noori N, Kalantar-Zadeh K, Kovesdy C, Murali S, Bross R, Nissenson A . Dietary potassium intake and mortality in long-term hemodialysis patients. Am J Kidney Dis. 2010; 56(2):338-47. PMC: 2910783. DOI: 10.1053/j.ajkd.2010.03.022. View

19.

El Amouri A, Delva K, Foulon A, Vande Moortel C, van Hoeck K, Glorieux G . Potassium and fiber: a controversial couple in the nutritional management of children with chronic kidney disease. Pediatr Nephrol. 2022; 37(7):1657-1665. DOI: 10.1007/s00467-021-05365-5. View

20.

Naismith D, Braschi A . An investigation into the bioaccessibility of potassium in unprocessed fruits and vegetables. Int J Food Sci Nutr. 2008; 59(5):438-50. DOI: 10.1080/09637480701690519. View